Publication:
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: a UCARE study

dc.contributor.coauthorMaurer, Marcus
dc.contributor.coauthorWeller, Karsten
dc.contributor.coauthorMagerl, Markus
dc.contributor.coauthorMaurer, Rasmus Robin
dc.contributor.coauthorVanegas, Emanuel
dc.contributor.coauthorFelix, Miguel
dc.contributor.coauthorCherrez, Annia
dc.contributor.coauthorMata, Valeria L.
dc.contributor.coauthorKasperska-Zajac, Alicja
dc.contributor.coauthorSikora, Agnieszka
dc.contributor.coauthorFomina, Daria
dc.contributor.coauthorKovalkova, Elena
dc.contributor.coauthorGodse, Kiran
dc.contributor.coauthorRao, Nimmagadda Dheeraj
dc.contributor.coauthorKhoshkhui, Maryam
dc.contributor.coauthorRastgoo, Sahar
dc.contributor.coauthorJardim Criado, Roberta Fachini
dc.contributor.coauthorAbuzakouk, Mohamed
dc.contributor.coauthorGrandon, Deepa
dc.contributor.coauthorvan Doorn, Martijn
dc.contributor.coauthorValle, Solange Olliveira Rodrigues
dc.contributor.coauthorLima, Eduardo Magalhaes de Souza
dc.contributor.coauthorThomsen, Simon Francis
dc.contributor.coauthorRamon, German D.
dc.contributor.coauthorBenavides, Edgar E. Matos
dc.contributor.coauthorBauer, Andrea
dc.contributor.coauthorGimenez-Arnau, Ana Maria
dc.contributor.coauthorGuillet, Carole
dc.contributor.coauthorLarco, Jose Ignacio
dc.contributor.coauthorZhao, Zuo-Tao
dc.contributor.coauthorMakris, Michael
dc.contributor.coauthorRitchie, Carla
dc.contributor.coauthorXepapadakia, Paraskevi
dc.contributor.coauthorEnsina, Luis Felipe
dc.contributor.coauthorCherrez, Sofia
dc.contributor.coauthorCherrez-Ojeda, Ivan
dc.contributor.kuauthorKocatürk Göncü, Özgür Emek
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid217219
dc.date.accessioned2024-11-09T11:45:32Z
dc.date.issued2020
dc.description.abstractBackground: chronic urticaria (CU) is characterized by itchy recurrent wheals, angioedema, or both for 6 weeks or longer. CU can greatly impact patients' physical and emotional quality of life. Patients with chronic conditions are increasingly seeking information from information and communications technologies (ICTs) to manage their health. The objective of this study was to assess the frequency of usage and preference of ICTs from the perspective of patients with CU. Methods: in this cross-sectional study, 1800 patients were recruited from primary healthcare centers, university hospitals or specialized clinics that form part of the UCARE (Urticaria Centers of Reference and Excellence) network throughout 16 countries. Patients were >12 years old and had physician-diagnosed chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CIndU). Patients completed a 23-item questionnaire containing questions about ICT usage, including the type, frequency, preference, and quality, answers to which were recorded in a standardized database at each center. For analysis, ICTs were categorized into 3 groups as follows: one-to-one: SMS, WhatsApp, Skype, and email; one-to-many: YouTube, web browsers, and blogs or forums; many-to-many: Instagram, Twitter, Facebook, and LinkedIn. Results: overall, 99.6% of CU patients had access to ICT platforms and 96.7% had internet access. Daily, 85.4% patients used one-to-one ICT platforms most often, followed by one-to-many ICTs (75.5%) and many-to-many ICTs (59.2%). The daily ICT usage was highest for web browsers (72.7%) and WhatsApp (70.0%). The general usage of ICT platforms increased in patients with higher levels of education. One-to-many was the preferred ICT category for obtaining general health information (78.3%) and for CU-related information (75.4%). A web browser (77.6%) was by far the most commonly used ICT to obtain general health information, followed by YouTube (25.8%) and Facebook (16.3%). Similarly, for CU-specific information, 3 out of 4 patients (74.6%) used a web browser, 20.9% used YouTube, and 13.6% used Facebook. One in 5 (21.6%) patients did not use any form of ICT for obtaining information on CU. The quality of the information obtained from one-to-many ICTs was rated much more often as very interesting and of good quality for general health information (53.5%) and CU-related information (51.5%) as compared to the other categories. Conclusions: usage of ICTs for health and CU-specific information is extremely high in all countries analyzed, with web browsers being the preferred ICT platform.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue11
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipWorld Allergy Organization
dc.description.sponsorshipAllakos
dc.description.sponsorshipAlnylam
dc.description.sponsorshipAralez
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipBiocryst
dc.description.sponsorshipBlueprint
dc.description.sponsorshipCSL Behring
dc.description.sponsorshipFAES
dc.description.sponsorshipGenentech
dc.description.sponsorshipKalvista Pharmaceuticals
dc.description.sponsorshipLEO Pharma
dc.description.sponsorshipMenarini
dc.description.sponsorshipMoxie
dc.description.sponsorshipMSD
dc.description.sponsorshipNovartis
dc.description.sponsorshipPharming
dc.description.sponsorshipPharvaris
dc.description.sponsorshipRoche
dc.description.sponsorshipSanofi
dc.description.sponsorshipShire/Takeda
dc.description.sponsorshipUCB
dc.description.sponsorshipDr. Pfleger
dc.description.sponsorshipUriach
dc.description.sponsorshipGlaxo SmithKline
dc.description.sponsorshipAbbvie
dc.description.sponsorshipBMS
dc.description.sponsorshipCelgene
dc.description.sponsorshipJanssen Cilag
dc.description.sponsorshipLilly
dc.description.sponsorshipPfizer
dc.description.sponsorshipSanofi-Genzyme
dc.description.sponsorshipEli Lilly
dc.description.sponsorshipJanssen
dc.description.sponsorshipPierre Fabre
dc.description.sponsorshipInstituto Carlos III- FEDER
dc.description.sponsorshipBayer
dc.description.sponsorshipChiesi
dc.description.sponsorshipGalenica Greece
dc.description.sponsorshipNestle
dc.description.sponsorshipNutricia
dc.description.sponsorshipTakeda
dc.description.versionPublisher version
dc.description.volume13
dc.formatpdf
dc.identifier.doi10.1016/j.waojou.2020.100475
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02545
dc.identifier.issn1939-4551
dc.identifier.linkhttps://doi.org/10.1016/j.waojou.2020.100475
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85094607302
dc.identifier.urihttps://hdl.handle.net/20.500.14288/476
dc.identifier.wos595304300001
dc.keywords(3–5) ICT
dc.keywordsInformation and communications technology
dc.keywordsSelf-management
dc.keywordsUrticaria
dc.languageEnglish
dc.publisherElsevier
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9183
dc.sourceWorld Allergy Organization Journal
dc.subjectMedicine
dc.subjectAllergy
dc.subjectImmunology
dc.titleThe usage, quality and relevance of information and communications technologies in patients with chronic urticaria: a UCARE study
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0003-2801-0959
local.contributor.kuauthorKocatürk Göncü, Özgür Emek

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
9183.pdf
Size:
1009.73 KB
Format:
Adobe Portable Document Format